STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.79
−2.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2370.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.23x
- Price / sales
- 681.47x
- Price / cash flow
- -16.61x
Enterprise value
- Enterprise value
- $620.8M
- EV / sales
- 620.84x
- EV / EBITDA
- -12.81x
- EV / EBIT
- -11.13x
- Market cap
- $681.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026